Atlas Trials

Preop fSRS for Resectable Brain Metastases

Clinical trial NCT05267587 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05267587
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Brain MetastasesBrain Lesion
Start date
2022-03-11
Primary completion
2025-05-29
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.